SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (2886)3/20/1998 8:58:00 PM
From: Brander  Read Replies (1) of 7041
 
Hank, first of all, what you are doing is splitting hairs. If the FDA took the approach you are suggesting, they could find significant differences in any new medication when compared to another. Second of all, I don't know where you got your stats from, but they are not correct. Here are the correct ones:
Paxil: Somnolence 23.3%
Impotence 6.4 % (now known to be much higher)
Headaches 17.6 %

Zoloft: Somnolence 13.4 %
Impotence 7.0 % (now known to be much higher)
Headaches 20.3 %

Source: SmithKline and Roerig pkg Inserts

These are no differences between the above side effects clinically. If you are saying that these differences are enough for the FDA to determine that one drug is more efficacious in some way over another, then this rule is meaningless.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext